GHOST TREE CAPITAL
GHOST TREE CAPITAL, LLC Legal Name
Adviser information for GHOST TREE CAPITAL last updated from Form ADV on March 14th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 8 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 6 | $360.0M |
Non-Discretionary | 0 | $0 |
Total | 6 | $360.0M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 6 | $360.0M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 0 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based feesPERFORMANCE-BASED ALLOCATIONS |
Principal Office
667 MADISON AVENUE5TH FLOOR, SUITE 12
NEW YORK
NY
United States
Monday - Friday, 8 A.M. TO 6 P.M.
Tel: 646-779-0120, Fax: None
Chief Compliance Officer
MATTHEW JAMES DIAZ
CHIEF FINANCIAL OFFICER, CHIEF OPERATING OFFICER
110 FRONT STREET
SUITE 300
JUPITER
FL
United States
Tel:
646-779-0121
M*@***************M
(Full email address available in API data)
Regulatory Contact
DAVID Y. KIM
CHIEF INVESTMENTS OFFICER
200 DORADO BEACH DRIVE
3732 WEST BEACH RESIDENCE
DORADO
PR
United States
Tel:
646-779-0123
D*@***************M
(Full email address available in API data)
Industry Affiliates
PORTALEDGE, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
GHOST TREE MASTER FUND, LP | Hedge Fund | $83.0M | $1.0M | 6 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
KIM, DAVID, YOUNG-JAE | Individual | – | PORTFOLIO MANAGER, MANAGING MEMBER | 02/2013 | < 5% |
DIAZ, MATTHEW, JAMES | Individual | – | CHIEF FINANCIAL OFFICER, CHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER | 08/2018 | < 5% |
GHOST TREE CAPITAL MANAGEMENT, LP | Domestic Entity | – | OWNER | 06/2015 | > 75% |
KIM, DAVID, YOUNG-JAE | Individual | GHOST TREE CAPITAL MANAGEMENT, LP | MANAGING PARTNER; OWNER | 02/2013 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ACADIA PHARMACEUTICALS INC | COM | 4M | 225K | – |
ALNYLAM PHARMACEUTICALS INC | COM | 5M | 23K | – |
ALNYLAM PHARMACEUTICALS INC | COM | 17M | 68K | – |
AN2 THERAPEUTICS INC | COM | 472K | 219K | – |
ANNEXON INC | COM | 2M | 310K | – |
ANNEXON INC | COM | 1M | 215K | – |
APELLIS PHARMACEUTICALS INC | COM | 5M | 135K | – |
ARROWHEAD PHARMACEUTICALS IN | COM | 910K | 35K | – |
ARVINAS INC | COM | 2M | 75K | – |
ASCENDIS PHARMA A/S | SPONSORED ADR | 12M | 87K | – |
ATYR PHARMA INC | COM NEW | 1M | 800K | – |
AXSOME THERAPEUTICS INC | COM | 12M | 150K | – |
BIOHAVEN LTD | COM | 17M | 490K | – |
BLUEPRINT MEDICINES CORP | COM | 4M | 40K | – |
BRIDGEBIO PHARMA INC | COM | 4M | 140K | – |
CABALETTA BIO INC | COM | 3M | 371K | – |
CG ONCOLOGY INC | COM | 8M | 260K | – |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 8M | 175K | – |
CRINETICS PHARMACEUTICALS IN | COM | 11M | 240K | – |
CYTOKINETICS INC | COM NEW | 2M | 33K | – |
CYTOMX THERAPEUTICS INC | COM | 366K | 300K | – |
ELEVATION ONCOLOGY INC | COM | 2M | 600K | – |
ENGENE HOLDINGS INC | COM | 4M | 420K | – |
HELIX ACQUISITION CORP II | CL A ORD SHS | 3M | 300K | – |
IMMUNOVANT INC | COM | 7M | 260K | – |
INSMED INC | COM PAR $.01 | 4M | 65K | – |
INSMED INC | COM PAR $.01 | 13M | 200K | – |
INTELLIA THERAPEUTICS INC | COM | 560K | 25K | – |
INTRA-CELLULAR THERAPIES INC | COM | 685K | 10K | – |
JANUX THERAPEUTICS INC | COM | 2M | 50K | – |
KORRO BIO INC | COM | 3M | 100K | – |
KRYSTAL BIOTECH INC | COM | 2M | 9K | – |
MACROGENICS INC | COM | 638K | 150K | – |
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 13M | 300K | – |
NEUROGENE INC | COM | 3M | 70K | – |
NUVATION BIO INC | COM CL A | 3M | 1M | – |
OLEMA PHARMACEUTICALS INC | COM | 6M | 550K | – |
PERSPECTIVE THERAPEUTICS INC | COM NEW | 9M | 925K | – |
PHATHOM PHARMACEUTICALS INC | COM | 6M | 600K | – |
PMV PHARMACEUTICALS INC | COM | 608K | 375K | – |
PROQR THRAPEUTICS N V | SHS EURO | 1M | 900K | – |
PTC THERAPEUTICS INC | COM | 581K | 19K | – |
RAPT THERAPEUTICS INC | COM | 915K | 300K | – |
REGENXBIO INC | COM | 2M | 170K | – |
REPLIMUNE GROUP INC | COM | 4M | 450K | – |
REVANCE THERAPEUTICS INC | COM | 578K | 225K | – |
REZOLUTE INC | COM NEW | 6M | 1M | – |
RHYTHM PHARMACEUTICALS INC | COM | 5M | 117K | – |
ROIVANT SCIENCES LTD | SHS | 11M | 1M | – |
SAGIMET BIOSCIENCES INC | COM SER A | 770K | 225K | – |
SAREPTA THERAPEUTICS INC | COM | 9M | 55K | – |
SAVARA INC | COM | 4M | 1M | – |
SOLENO THERAPEUTICS INC | COM | 12M | 300K | – |
SPYRE THERAPEUTICS INC | COM NEW | 6M | 250K | – |
SYNDAX PHARMACEUTICALS INC | COM | 7M | 350K | – |
TARSUS PHARMACEUTICALS INC | COM | 6M | 235K | – |
TAYSHA GENE THERAPIES INC | COM SHS | 3M | 1M | – |
TENAYA THERAPEUTICS INC | COM | 4M | 1M | – |
TG THERAPEUTICS INC | COM | 9M | 500K | – |
VAXCYTE INC | COM | 11M | 150K | – |
VIKING THERAPEUTICS INC | COM | 5M | 95K | – |
VIRIDIAN THERAPEUTICS INC | COM | 8M | 588K | – |
WAVE LIFE SCIENCES LTD | SHS | 998K | 200K | – |